
Sign up to save your podcasts
Or
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PUG865. CME/MOC/AAPA/IPCE credit will be available until November 20, 2025.
Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.
Disclosure information is available at the beginning of the video presentation.
3.5
2727 ratings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PUG865. CME/MOC/AAPA/IPCE credit will be available until November 20, 2025.
Early Diagnosis and Evolving Management of Eosinophilic Esophagitis in the Era of Targeted Therapy
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.
Disclosure information is available at the beginning of the video presentation.
129 Listeners
6 Listeners
3 Listeners
3 Listeners
10 Listeners
5 Listeners
9 Listeners
3 Listeners
2 Listeners
5 Listeners
3 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
1,866 Listeners
525 Listeners
2 Listeners
965 Listeners
10 Listeners
2 Listeners
487 Listeners
690 Listeners
270 Listeners
255 Listeners
3,323 Listeners
85 Listeners
1,090 Listeners
184 Listeners
517 Listeners
243 Listeners
362 Listeners